The Emergence of a Novel Synthetic Nicotine Analog 6‐Methyl Nicotine (6‐MN) in Proclaimed Tobacco‐ and Nicotine‐Free Pouches Available in Europe

A new nicotine delivery system in the form of tobacco-free nicotine pouches was introduced in Europe in 2019. These nicotine bags did not fall under the Tobacco Products Directive (TPD) II, which brought forward regulatory requirements for both cigarettes, related products, and e-liquids. As these pouches did not fall under the scope of the TPD, it was up to the member states to decide which action to be taken if any. Some EU member states banned these nicotine pouches, while others put restrictions on the amount of nicotine, warning messages, and presentation and packaging of the product, and some member states did not take any action. Likely as a result of the ban or restrictions, soon after also, tobacco and nicotine-free pouches became available in the European Union (EU). Early 2024, "NoNIC" pouches, claiming to be tobacco- and nicotine-free, became available on the European market. These pouches are promoted online and clearly target a younger population with a youth-appealing package design and enticing flavors. Upon analysis of different samples utilizing gas chromatography coupled to MS (GC-MS), liquid chromatography coupled to high-resolution tandem mass spectrometry (HRAM LC-MS2), and nuclear magnetic resonance spectroscopy (NMR), it was demonstrated that these pouches were indeed devoid of nicotine but contained the synthetic nicotine homolog 6-methyl nicotine (6-MN) and this up to 20 mg per pouch. Nonetheless, a part of a likely unaware/misled young adult subpopulation has easy access to these products, containing a novel molecule for which limited to no clinical effects are known.

Authors

Institutions

Publication Details

Journal
Drug Testing and Analysis
Published
2024-12-19
DOI
https://doi.org/10.1002/dta.3841
Citations
7
Primary Topic
Smoking Behavior and Cessation
Type
article
Field-Weighted Citation Impact
2.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Emergence of a Novel Synthetic Nicotine Analog 6‐Methyl Nicotine (6‐MN) in Proclaimed Tobacco‐ and Nicotine‐Free Pouches Available in Europe

Céline Vanhee, Sophia Barhdadi, Michaël Canfyn, Emmy Tuenter et al.
7 citations
Drug Testing and Analysis
Smoking Behavior and Cessation
2.29
article

The Emergence of a Novel Synthetic Nicotine Analog 6‐Methyl Nicotine (6‐MN) in Proclaimed Tobacco‐ and Nicotine‐Free Pouches Available in Europe

Céline Vanhee, Sophia Barhdadi, Michaël Canfyn, Emmy Tuenter, Maarten Dill
article en
7 citations

Abstract

A new nicotine delivery system in the form of tobacco-free nicotine pouches was introduced in Europe in 2019. These nicotine bags did not fall under the Tobacco Products Directive (TPD) II, which brought forward regulatory requirements for both cigarettes, related products, and e-liquids. As these pouches did not fall under the scope of the TPD, it was up to the member states to decide which action to be taken if any. Some EU member states banned these nicotine pouches, while others put restrictions on the amount of nicotine, warning messages, and presentation and packaging of the product, and some member states did not take any action. Likely as a result of the ban or restrictions, soon after also, tobacco and nicotine-free pouches became available in the European Union (EU). Early 2024, "NoNIC" pouches, claiming to be tobacco- and nicotine-free, became available on the European market. These pouches are promoted online and clearly target a younger population with a youth-appealing package design and enticing flavors. Upon analysis of different samples utilizing gas chromatography coupled to MS (GC-MS), liquid chromatography coupled to high-resolution tandem mass spectrometry (HRAM LC-MS2), and nuclear magnetic resonance spectroscopy (NMR), it was demonstrated that these pouches were indeed devoid of nicotine but contained the synthetic nicotine homolog 6-methyl nicotine (6-MN) and this up to 20 mg per pouch. Nonetheless, a part of a likely unaware/misled young adult subpopulation has easy access to these products, containing a novel molecule for which limited to no clinical effects are known.

Drug Testing and AnalysisVol. 17(8)
University of Antwerp (BE), Directorate-General for Health and Food Safety (BE), Sciensano (Belgium) (BE)
Good health and well-being
Openalex Percentile: Top 11%
Smoking Behavior and Cessation
2.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.